Blog
Vita Coco CFO Sells 4000 Shares as Stock Sets to Join S&P SmallCap 600
Corey Baker, Chief Financial Officer of The Vita Coco Company, Inc. (NASDAQ:COCO), disclosed the sale of 4,000 shares of common stock on March 17, 2026 and March 18, 2026, as detailed in the SEC
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash
DAFNA Capital Management reported a buy of 720,000 shares of Biohaven (NYSE:BHVN) in a February 17, 2026, SEC filing, with the estimated transaction value at $8.92 million based on quarterly average
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
RTW Investments initiated a new stake in Apellis Pharmaceuticals (NASDAQ:APLS), acquiring 7,666,764 shares in the fourth quarter, according to a February 17, 2026, SEC filing.
An SEC filing dated
What Happens to Your Investments If the Stock Market Crashes?
More than half of U.S. investors feel pessimistic about the market's future, according to the most recent weekly survey from the American Association of Individual Investors, published on March 18
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
RTW Investments disclosed a significant buy of Cogent Biosciences (NASDAQ:COGT) in its February 17, 2026, SEC filing, adding 4,124,755 shares in a trade estimated at $115.95 million based on
Why Scholastic Stock Climbed This Week
Shares of Scholastic (NASDAQ: SCHL) rose this past week after the children's education and media leader's quarterly results earned higher marks than investors expected.
According to data from S&P
Why This $18 Million Sale Might Signal a Shift as a China Tech Bet Falls 34%
RWC Asset Advisors (US) LLC disclosed a sale of 834,689 shares of Kanzhun Limited (NASDAQ:BZ) in its February 17, 2026, SEC filing, an estimated $18.03 million trade based on quarterly average
Should Tesla Be Worried About Rivian?
For years, Tesla (NASDAQ: TSLA) has had much of the U.S. EV market to itself. There's a reason why Tesla's market cap is well above $1 trillion, while most other EV stocks are valued at less than
Is Apple Stock Going to $500? Here's What Has to Happen.
Apple's (NASDAQ: AAPL) past is defined by its winning performance. Shares have skyrocketed a jaw-dropping 953%, including dividends, in the last decade (as of March 17). This is impressive given the
Is Micron the Next Nvidia?
Micron (NASDAQ: MU) reported fantastic quarterly financial results, yet the stock is still falling.
*Stock prices used were the afternoon prices of March 19, 2026. The video was published on March
Reddit Stock is Crashing: Is This a Generational Buying Opportunity?
Reddit (NYSE: RDDT) is one of the fastest-growing social media companies in the world.
*Stock prices used were the afternoon prices of March 19, 2026. The video was published on March 21, 2026.
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
On February 17, 2026, FCPM III Services B.V. disclosed a buy of 1,489,096 RAPT Therapeutics (NASDAQ:RAPT) shares, an estimated $46.24 million trade based on quarterly average pricing.
According to
Why Is SoFi Stock Crashing, and Should You Buy the Dip?
For several months, I had been warning investors that SoFi (NASDAQ: SOFI) stock was too expensive. Since my warnings, the stock has crashed to lower levels.
*Stock prices used were the afternoon
Is This Stock a Buy on the Dip?
After becoming the first healthcare stock to hit a $1 trillion market valuation in late 2025, Eli Lilly (NYSE: LLY) hasn't performed well since, with its shares down about 19% from their 52-week
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
Kynam Capital Management disclosed in a February 17, 2026, SEC filing that it sold 1,720,949 shares of Cogent Biosciences (NASDAQ:COGT), an estimated $48.38 million trade based on quarterly average
Bristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?
Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
On March 2, 2026, Jennifer Dawn Whalen, SVP, CFO of Bristow
Uber's Advertising Business May Be Bigger Than Investors Think
Investors typically think of Uber Technologies (NYSE: UBER) as a ride-hailing and food delivery company. And for good reason -- those businesses still drive the majority of its revenue and growth.
This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know
Kynam Capital Management trimmed its stake in Viridian Therapeutics (NASDAQ:VRDN), selling 2,957,386 shares in the fourth quarter, an estimated $81.11 million transaction based on quarterly average
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know
Kynam Capital Management reduced its position in CG Oncology (NASDAQ:CGON), selling 1,059,375 shares in the fourth quarter for an estimated $43.84 million based on quarterly average pricing
This Nuclear Energy Trend Could Be Bigger Than Investors Think in 2026
Nuclear energy is being considered as a potential solution to the incredible demand for electricity created by artificial intelligence (AI) and the data centers it requires.
By 2028, according to
Before Retiring, Warren Buffett Left Investors With a $373 Billion Warning. Here's What History Says the Stock Market Will Do Next.
Warren Buffett stepped down as CEO of Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) at the start of the year, but his legacy will live on forever. In just over 60 years at the helm of the company, he
Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish
Kynam Capital Management disclosed in a February 17, 2026, Securities and Exchange Commission (SEC) filing that it sold 469,041 shares of Syndax Pharmaceuticals (NASDAQ:SNDX), an estimated $8.18
Is Berkshire Hathaway Stock a Buy Right Now?
It is a new era in Omaha, as investing legend Warren Buffett retired at the end of 2025 after roughly 60 years leading Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) and growing it into one of the
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
According to an SEC filing dated February 17, 2026, DAFNA Capital Management LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 34,405 shares during the fourth quarter of 2025. The
EV Stocks Have Massive Upside, but Investors Need to Avoid This Profit Blackhole
Getting into global trends early, one way or another, is an ideal way to find lucrative long-term investment wins -- but it's certainly easier said than done. Electric vehicle (EV) makers have


